Trial Profile
Real-World Study of Apatinib in the Treatment of Advanced Lung Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 07 Sep 2018 New trial record